Related Experiment Videos
A novel murine PDGF-D splicing variant results in significant differences in peptide expression and function
Ying Zhuo1, Gary W Hoyle, Jian Zhang
1Tulane University Health Sciences Center, Departments of Medicine and Pathology, 1430 Tulane Avenue, New Orleans, LA 70112-2699, USA.
Biochemical and Biophysical Research Communications
|August 2, 2003
Summary
Researchers found a splicing variant in mouse Platelet-Derived Growth Factor-D (PDGF-D) not present in humans. This variant may affect PDGF-D
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Platelet-Derived Growth Factor (PDGF) is a key regulator of cell growth and migration.
- PDGF isoforms, particularly PDGF-D, are implicated in fibroproliferative diseases.
- Understanding species-specific differences in PDGF signaling is crucial for disease modeling.
Purpose of the Study:
- To identify and characterize splicing variants of PDGF-D.
- To investigate differences in PDGF-D gene expression between mice and humans.
- To assess the potential impact of identified variants on PDGF-D function.
Main Methods:
- Bioinformatic analysis of gene sequences.
- Splicing site analysis.
- In silico prediction of protein structure and function.
Main Results:
- A novel splicing variant of the PDGF-D isoform was identified in mice.
- This variant was not found in human PDGF-D sequences.
- The variant results from an aberrant splicing site at the exon 5 and 6 junction, leading to a deletion within the cysteine knot domain.
- The deletion is predicted to impair peptide dimerization and receptor binding, affecting PDGF-D activity.
Conclusions:
- A significant difference in PDGF-D splicing exists between mice and humans.
- The identified murine PDGF-D splicing variant may alter its biological activity.
- These findings highlight the importance of considering murine-specific genetic variations when using mouse models for human fibroproliferative diseases.